Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Intellectual functioning in individuals with Bardet-Biedl syndrome.
Journal: The Clinical neuropsychologist
Published: April 08, 2026
Clinical burden of hyperphagia, obesity and health outcomes in paediatric individuals with Bardet-Biedl syndrome: A CRIBBS data analysis.
Journal: Pediatric obesity
Published: December 20, 2024
Early development and adaptive functioning in children with Bardet-Biedl syndrome.
Journal: American journal of medical genetics. Part A
Published: January 05, 2023
Interview-Based Patient- and Caregiver-Reported Experiences of Hunger and Improved Quality of Life with Setmelanotide Treatment in Bardet-Biedl Syndrome.
Journal: Advances in therapy
Published: December 22, 2022
Quality of life improvements following one year of setmelanotide in children and adult patients with Bardet-Biedl syndrome: phase 3 trial results.
Journal: Orphanet journal of rare diseases
Published: August 15, 2022
Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period.
Journal: The lancet. Diabetes & endocrinology
Published: April 04, 2022
Sleep and physical activity patterns in adults and children with Bardet-Biedl syndrome.
Journal: Orphanet journal of rare diseases
Published: February 22, 2021
The efficacy and safety of setmelanotide in individuals with Bardet-Biedl syndrome or Alström syndrome: Phase 3 trial design.
Journal: Contemporary clinical trials communications
Published: November 03, 2020
Bardet-Biedl syndrome: Weight patterns and genetics in a rare obesity syndrome.
Journal: Pediatric obesity
Published: May 22, 2020
Effect of setmelanotide, a melanocortin-4 receptor agonist, on obesity in Bardet-Biedl syndrome.
Journal: Diabetes, obesity & metabolism
Published: May 20, 2020
An international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes.
Journal: Kidney international
Published: April 23, 2020
Last Updated: 09/26/2026